An open-label, pilot study to evaluate the benefits of using lyophilized human milk-derived nutritional product (NeoLact 70 – 1.55 g) as an immune-nutritional supplement in premature infants discharged from NICU. Indian J Child Health. 2021;8(12):404-407. doi:10.32677/ijch.v8i12.3213